IFM Therapeutics

www.ifmthera.com
800 Boylston St, Unit 990288
Cambridge, MA 2199

Company Info

Year Established
2015

Ticker
NVS

Exchange
NYSE

Contacts

H. Martin Seidel
CEO

Dennis Dean
CDO

Christopher M. Lindblom
VP, Finance

Company Description

IFM Therapeutics, a Novartis company, is a pharmaceutical company focused on developing biological treatments for autoimmune diseases.

Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.